PEP
41
-3
KMI
53
2
WDC
41
3
NAVI
47
6
MPC
44
5
PG
51
-13
EMC
89
6
MS
62
7
LEG
37
6
BRK.B
40
-2
SLB
55
2
GILD
63
-4
CHD
50
-6
NVDA
61
5
WU
20
8
SHW
53
-6
NWL
8
2
MAT
49
2
DHI
31
3
APA
32
2
PEP
41
-3
KMI
53
2
WDC
41
3
NAVI
47
6
MPC
44
5
PG
51
-13
EMC
89
6
MS
62
7
LEG
37
6
BRK.B
40
-2
SLB
55
2
GILD
63
-4
CHD
50
-6
NVDA
61
5
WU
20
8
SHW
53
-6
NWL
8
2
MAT
49
2
DHI
31
3
APA
32
2
Financhill
Back

Pediatrix Medical Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
52

MD
Pediatrix Medical Group

Last Price:
$14.37
Seasonality Move:
-2.75%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.29
Seasonality Move:
1.75%
Buy
52
Pediatrix Medical Group (MD) is a Buy

Is Pediatrix Medical Group a Buy, Sell or Hold?

  • The current Pediatrix Medical Group [MD] share price is $14.05. The Score for MD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • MD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MD Stock Price Chart

What is Pediatrix Medical Group's stock price today?

  • The Pediatrix Medical Group share price today is $14.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MD is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 50.5 Buy
Chaikin Money Flow: -375343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.54 - 14.44) Buy
Bollinger Bands (100): (12.33 - 14.89) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

MD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.09 Sell
20-day SMA: 14.13 Sell
50-day SMA: 13.93 Buy
200-day SMA: 11.12 Buy
8-day EMA: 14.17 Sell
20-day EMA: 14.05 Sell
50-day EMA: 13.89 Buy
200-day EMA: 12.24 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Pediatrix Medical Group Earnings Growth & MD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.08 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Pediatrix Medical Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):